PED/SAM 2020 kits in stock - and new brochure released!
In addition to the Interagency Emergency Health Kit (IEHK) 2024, we keep PED/SAM (Paediatric and Severe Acute Malnutrition) kits in stock for immediate delivery from our warehouse in Kandla, India.
To support this, we are pleased to introduce our new PED/SAM brochure, providing detailed information on the kit’s purpose, contents and use in emergency settings.
The PED/SAM kit is a comprehensive solution designed to equip healthcare providers with essential medicines, medical supplies and equipment to treat up to 50 children with severe acute malnutrition and medical complications. It is tailored to support a paediatric inpatient ward of 10–15 beds for approximately three months.
Missionpharma maintains ready stock of PED/SAM kits and can dispatch within 48 hours in response to humanitarian emergencies or disasters.
Healthcare supplies in stock
We offer more than 350 essential medicines and medical supplies from stock for immediate delivery!
We recognise the critical need to promptly meet our customers’ demands for healthcare products when a crisis hits.
Therefore, we offer more than 350 of essential medicines and medical supplies directly from stock. Products cover essential medicines recommended by the WHO, supplemented by an extensive selection of medical supplies and emergency kits, such as such as WHO IEHK kits and WHO PED/SAM kits.
Inventory is stored in our GDP-certified warehouses in India and Denmark, which ensures efficient distribution to our customers worldwide.
Learn more about our recent initiative to ensure a prompt response to your healthcare needs here.
Download the most recent version of our product catalogue. Product offerings are continuously updated. If you require an item that is not included in this catalogue, please contact us and we will be pleased to source it for you.
Releasing our Sustainability Report 2024-25
We are excited to share our new Sustainability Report for the financial year 2024-25. The report details our ongoing commitments under the UN Global Compact’s principles, with a strong focus on our Environmental, Social, and Governance (ESG) priorities, supported by the Sustainable Development Goals.
At Missionpharma, we are committed to running a sustainable business and to actively taking responsibility for the society and the environment in which we operate.
Our history is marked by our ability to deliver healthcare products globally, significantly improving the lives of more than 100 million people annually. We take great pride in this impact. As a company delivering essential healthcare, it is crucial for us to contribute positively to the world around us, and our mission for better health has never felt more relevant.
Proud participant of the UN Global Compact
Missionpharma has been an active participant of the UN Global Compact since 2018, and we commit to the principles of responsible business conduct promoted by the UN Global Compact and supported by the Sustainable Development Goals.
We particularly support SDG 3: Good Health and Well-Being, SDG 8: Decent work and Economic Growth, SDG 13: Climate Action and SDG 17: Partnership for the Goals.
Download our 2024/25 Sustainability report
Read more about our sustainability efforts
We are Missionpharma
For five decades, we have impacted people around the world with our products and our services. As one of the world's largest pharmaceutical wholesalers, we work to provide access to safe healthcare for everyone. Every year more than 100 million people worldwide are treated with medicine from Missionpharma.
We fundamentally believe that access to safe and affordable treatment is a human right, why our core focus is to provide quality medicine and medical devices to vulnerable communities all over the world.
We are determined to make a positive impact on the lives of millions of people globally and to prove our purpose of being on a mission for better health.
In financial year 2024/25 Missionpharma delivered 37,000 cbm of healthcare products to patients worldwide. This corresponds to 1,400 containers per year or almost 4 containers per day.
Hospital ships that transform lives
In 2023 Missionpharma entered into a long-term partnership with the international humanitarian organisation, Mercy Ships. Mercy Ships operates two hospital ships that offer free surgical operations to the poorest people in Africa.
For many people in low-income countries, surgery is simply not an option, either because it doesn’t exist or it is inaccessible. Onboard the two floating hospital ships, Mercy Ships provides safe surgery for free, transforming thousands of lives in every country it visits.

Mercy Ships operates the two large non-governmental hospital ships, the Africa Mercy and the Global Mercy. The ships bring necessary medical care, surgeries and capacity building to Africa and offer in total 12 operating theatres and nearly 300 patient beds.
Missionpharma’s donation to Mercy Ships in 2025 corresponds to 30 life-changing operations on board the ships.
Committed to making an impact
Missionpharma is a leading supplier of generic pharmaceuticals, medical consumables, hospital equipment and medical kits to public and private institutions, international development organisations and the UN. Every year we supply medicines to treat more than 100 million people worldwide.
We are committed to making an impact. We provide tailored healthcare solutions built on a deep insight and decades of experience. We have offices in Denmark, India, China and Zambia and employ 170 people. Our head office is based in Denmark, where we employ 65 people and from where our overall business activities are managed.
Since 2012, Missionpharma has been part of CFAO Healthcare, the healthcare division of CFAO Group – a major distributor of international brands in Africa. The Group has wholesale operations and local branches all over Africa.
Since 1975 Missionpharma has provided safe and affordable healthcare products to patients all over the world. We all take great pride in doing what we do to contribute to strengthening global healthcare.
Christian Overgaard, CEO, Missionpharma Group
English
Français





